Search / Trial NCT06617104

Autonomic Nervous System and Meridian Energy in Patients With Schizophrenia

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Sep 26, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking to understand how the autonomic nervous system and energy flow, based on traditional Chinese medicine concepts, differ between people diagnosed with schizophrenia and healthy individuals. The goal is to gain insights that could help in preventing illnesses and improving care for those with schizophrenia. Researchers want to find out how these areas relate to the health and well-being of participants.

To participate, individuals aged 18 to 65 who either have schizophrenia (and are currently stable with no recent changes in medication) or are healthy with no chronic illnesses are eligible. Participants will need to be able to communicate in Mandarin or Taiwanese. Those with certain health conditions, such as severe neurological disorders or cardiovascular issues, as well as pregnant women, will not be eligible. If you join the study, you can expect to undergo assessments related to your nervous system and energy levels while contributing to valuable research that may enhance the understanding and treatment of schizophrenia.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Disease group:
  • Diagnosed with schizophrenia by a physician (ICD-10 code F20, such as F20.0, F20.1, F20.2, F20.3, F20.5, F20.89, or F20.9), with stable condition, and has not had any changes in medication dosage or admission to a psychiatric acute care unit in the past 3 months.
  • Aged between 18 and 65 years.
  • Able to understand, speak, read, and write Mandarin or Taiwanese.
  • 2. Control group:
  • No history of chronic illness and no acute symptoms within the past month.
  • Aged between 18 and 65 years.
  • Able to understand, speak, read, and write Mandarin or Taiwanese.
  • Exclusion Criteria:
  • 1. Disease group:
  • Individuals with cardiovascular conditions, severe neurological disorders (e.g., organic brain disorders, early-stage dementia or diagnosed dementia), or substance abuse issues.
  • Individuals who have used medications affecting the autonomic nervous system within the past month, such as mood stabilizers, antidepressants, angiotensin-converting enzyme inhibitors inhibitors, β-blockers, or antiarrhythmics.
  • Individuals with metallic implants that could affect heart rate variability.
  • Individuals with involuntary and uncontrollable body tremors.
  • Women currently menstruating.
  • Pregnant women.
  • 2. Control group:
  • Individuals with cardiovascular conditions, severe neurological disorders (e.g., organic brain disorders, early-stage dementia or diagnosed dementia), or substance abuse issues.
  • Individuals who have used medications affecting the autonomic nervous system within the past month, such as psychiatric medications, angiotensin-converting enzyme inhibitors inhibitors, β-blockers, or antiarrhythmics .
  • Individuals with metallic implants that could affect heart rate variability.
  • Individuals with involuntary and uncontrollable body tremors.
  • Women currently menstruating.
  • Pregnant women.

About National Taiwan University Hospital

National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.

Locations

Taipei, , Taiwan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0